Literature DB >> 18506687

Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.

James R Cerhan1, Eric A Engels, Wendy Cozen, Scott Davis, Richard K Severson, Lindsay M Morton, Gloria Gridley, Patricia Hartge, Martha Linet.   

Abstract

The incidence of NHL has increased dramatically since at least the 1950s, and during this timeframe there has been a major increase in the use of blood transfusions, invasive surgical procedures and anesthesia, all of which can impact immune function. We evaluated these factors with NHL risk in a population-based study of 759 cases and 589 frequency-matched controls. Risk factor data were collected during in-person interviews. Unconditional logistic regression was used to estimate ORs and 95% CIs, adjusted for the matching factors. History of transfusion was associated with a 26% higher risk of NHL (95% CI 0.91-1.73), and the elevated risk was specific to transfusions first given 5-29 years before the reference date (OR = 1.69; 95% CI 1.08-2.62) and transfusions given for a medical condition (OR = 2.09; 95% CI 1.03-4.26). The total number of surgeries and dental procedures (OR = 1.53 for 26+ surgeries compared to 0-6; 95% CI 1.02-2.29) and to a lesser extent the total number of exposures to general or local/regional anesthesia (OR = 1.35 for 24+ times compared to 0-6; 95% CI 0.91-2.02) were positively associated with risk of NHL. Inclusion of transfusion and surgery or transfusion and anesthesia in the same model did not attenuate these associations. All results were broadly consistent for both DLBCL and follicular subtypes. Blood transfusions were associated with NHL risk, but appear to be a marker for underlying medical conditions. Multiple surgical procedures and/or repeated administration of anesthesia have not been previously reported to be associated with risk of NHL and these exposures warrant further evaluation. Published 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18506687      PMCID: PMC3913466          DOI: 10.1002/ijc.23561

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

Review 1.  Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

Authors:  E C Vamvakas; M A Blajchman
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 2.  Blood transfusions and non-Hodgkin's lymphoma.

Authors:  Eric J Chow; Elizabeth A Holly
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

3.  Cancer after total joint arthroplasty: a meta-analysis.

Authors:  Tracy Onega; John Baron; Todd MacKenzie
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

4.  Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.

Authors:  Sven Sandin; Henrik Hjalgrim; Bengt Glimelius; Klaus Rostgaard; Eero Pukkala; Johan Askling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

Review 5.  Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma.

Authors:  E C Vamvakas
Journal:  Transfus Med Rev       Date:  2000-07

6.  Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study.

Authors:  Eric J Chow; Elizabeth A Holly
Journal:  Am J Epidemiol       Date:  2002-04-15       Impact factor: 4.897

7.  Changing incidence of non-Hodgkin lymphomas in the United States.

Authors:  Christina A Clarke; Sally L Glaser
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

8.  Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement.

Authors:  R M Urban; J J Jacobs; M J Tomlinson; J Gavrilovic; J Black; M Peoc'h
Journal:  J Bone Joint Surg Am       Date:  2000-04       Impact factor: 5.284

9.  Comparison of surgical stress between laparoscopic and open colonic resections.

Authors:  U Hildebrandt; K Kessler; T Plusczyk; G Pistorius; B Vollmar; M D Menger
Journal:  Surg Endosc       Date:  2002-10-29       Impact factor: 4.584

10.  Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.

Authors:  J R Cerhan; R B Wallace; F Dick; J Kemp; A S Parker; W Zheng; T A Sellers; A R Folsom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-04       Impact factor: 4.254

View more
  11 in total

1.  Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  James R Cerhan; Eleanor Kane; Claire M Vajdic; Martha S Linet; Alain Monnereau; Leslie Bernstein; Silvia de Sanjose; Brian C-H Chiu; John J Spinelli; L Dal Maso; Yawei Zhang; Beth R Larrabee; Wendy Cozen; Alexandra G Smith; Jacqueline Clavel; Diego Serraino; Tongzhang Zheng; Elizabeth A Holly; Dennis D Weisenberger; Susan L Slager; Paige M Bracci
Journal:  Cancer Causes Control       Date:  2019-06-04       Impact factor: 2.506

2.  Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer.

Authors:  Matthias Reeh; Tarik Ghadban; Josephine Dedow; Eik Vettorazzi; Faik G Uzunoglu; Michael Nentwich; Stefan Kluge; Jakob R Izbicki; Yogesh K Vashist
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 3.  New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.

Authors:  Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers
Journal:  Expert Rev Anticancer Ther       Date:  2015-04-11       Impact factor: 4.512

4.  Blood transfusions and the subsequent risk of hematologic malignancies.

Authors:  Cindy M Chang; Scott C Quinlan; Joan L Warren; Eric A Engels
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

5.  Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.

Authors:  Cindy M Chang; Sophia S Wang; Bhavana J Dave; Smrati Jain; Mohammad A Vasef; Dennis D Weisenburger; Wendy Cozen; Scott Davis; Richard K Severson; Charles F Lynch; Nathaniel Rothman; James R Cerhan; Patricia Hartge; Lindsay M Morton
Journal:  Int J Cancer       Date:  2010-11-23       Impact factor: 7.396

6.  Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.

Authors:  Eva Erber; Unhee Lim; Gertraud Maskarinec; Laurence N Kolonel
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

7.  Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Martha S Linet; Claire M Vajdic; Lindsay M Morton; Anneclaire J de Roos; Christine F Skibola; Paolo Boffetta; James R Cerhan; Christopher R Flowers; Silvia de Sanjosé; Alain Monnereau; Pierluigi Cocco; Jennifer L Kelly; Alexandra G Smith; Dennis D Weisenburger; Christina A Clarke; Aaron Blair; Leslie Bernstein; Tongzhang Zheng; Lucia Miligi; Jacqueline Clavel; Yolanda Benavente; Brian C H Chiu
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

8.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

Authors:  Lindsay M Morton; Sophia S Wang; Wendy Cozen; Martha S Linet; Nilanjan Chatterjee; Scott Davis; Richard K Severson; Joanne S Colt; Mohammad A Vasef; Nathaniel Rothman; Aaron Blair; Leslie Bernstein; Amanda J Cross; Anneclaire J De Roos; Eric A Engels; David W Hein; Deirdre A Hill; Linda E Kelemen; Unhee Lim; Charles F Lynch; Maryjean Schenk; Sholom Wacholder; Mary H Ward; Shelia Hoar Zahm; Stephen J Chanock; James R Cerhan; Patricia Hartge
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

9.  Exploring risk factors for follicular lymphoma.

Authors:  Alexander J Ambinder; Pareen J Shenoy; Neha Malik; Alison Maggioncalda; Loretta J Nastoupil; Christopher R Flowers
Journal:  Adv Hematol       Date:  2012-09-18

10.  Cancer risk among 21st century blood transfusion recipients.

Authors:  T O Yang; B J Cairns; G K Reeves; J Green; V Beral
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.